MedTrace Logo

Prevalence of Antiphospholipid Antibodies Among Women With Preeclampsia

NCT02699437 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-10-30

No results posted yet for this study

Summary

The purpose of this study is to determine the prevalence of positive antiphospholipid antibodies among women with preeclampsia and to determine the effect of antiphospholipid antibodies on the severity of preeclampsia and the obstetric outcomes

Conditions

Interventions

OTHER

Testing for antiphospholipid antibodies

Blood samples will be tested for anticardiolipin antibodies and lupus anticoagulant

Sponsors & Collaborators

  • Mohamed Sayed Abdelhafez

    lead OTHER

Principal Investigators

  • Hanaa M El-Shafiey · Mansoura University

  • Mohamed S Abdelhafez, Dr · Mansoura University

  • Alaa El-Din M El-Gohary, Dr · Mansoura University

  • El-Said M Abd El-Hady, Prof · Mansoura University

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02699437 on ClinicalTrials.gov